U.S. Semiconductors Stock News

If you are wondering whether lululemon athletica's current share price truly reflects its underlying worth, you are not alone in questioning what you might be paying for today. The stock closed at US$163.45, with returns of 0.4% over the past week, a 0.6% decline over 30 days, and longer term returns of a 22.5% decline year to date, a 38.5% decline over 1 year, a 56.2% decline over 3 years, and a 51.7% decline over 5 years shaping sentiment around the name. Recent coverage has focused on how...

Nicolet Bankshares (NIC) opened 2026 with Q1 revenue of US$128.8 million and basic EPS of US$0.83, setting the tone for how investors will judge the latest set of numbers against the past year. Over recent periods, the company has seen quarterly revenue move from US$87.9 million in Q1 2025 to US$103.2 million in Q4 2025 and then to US$128.8 million in Q1 2026. Basic EPS shifted from US$2.14 to US$2.72 and then to US$0.83, putting the focus squarely on how sustainable earnings power and...

Earlier this month, Remitly Global launched the first cross-border money transfer app within ChatGPT, enabling users in the US, Canada, and the UK to compare real-time exchange rates and delivery options without leaving the platform, before completing transfers on Remitly’s own app or website. This move aligns with Remitly’s push into AI-powered channels, using conversational interfaces to make researching international transfers more convenient for customers already using ChatGPT. Next,...

EMCOR Group (EME) is back in focus as investors look ahead to its first quarter 2026 earnings report on April 29, following record 2025 results and a sizable project backlog. See our latest analysis for EMCOR Group. The recent strength in EMCOR Group’s 1 month share price return of 15.49% and year to date share price return of 34.66% comes on top of a very large 5 year total shareholder return. This suggests momentum has been building as investors reassess growth prospects and risks around...

Travel + Leisure (TNL) opened 2026 with Q1 revenue of US$961 million and basic EPS of US$1.26, while the trailing twelve months show total revenue of about US$4.0 billion and basic EPS of US$3.66. Over recent periods, revenue has moved from US$934 million in Q1 2025 to US$961 million in Q1 2026, with quarterly EPS shifting from US$1.09 a year ago to US$1.26 in the latest quarter, as investors weigh these headline figures against a thinner 5.8% net profit margin over the last year compared...

Consolidated Edison, NYSE:ED, is drawing attention as a dividend stock for retirees, supported by an above average yield and consistent dividend growth. The company continues to be viewed as a source of income at a current share price of $108.13. Income focused investors are watching NYSE:ED closely as steady dividends remain a priority in the current yield environment. For investors who put income first, Consolidated Edison, NYSE:ED, is a long running utility with a reputation for steady...

Cybin’s subsidiary Helus Pharma recently saw Executive Chairman and Co‑founder Eric So re‑assume the role of Interim CEO after the board requested Michael Cola’s departure, while also adding neuroscience veteran Dr. Ken Kramer as Senior Vice President of Medical Affairs. This combination of a board-driven leadership change and a high-profile medical affairs hire could influence how investors assess Helus’ execution capabilities within Cybin’s broader clinical platform. We’ll now examine how...

Wondering if NextEra Energy's current share price lines up with its underlying value, or if the recent run means you are late to the story? The stock last closed at US$90.00, with returns of 11.2% year to date and 37.8% over the past year, even though the 7-day and 30-day returns were 1.4% and 0.3% declines. Recent coverage has focused on NextEra Energy's role as a major US utilities player and how its scale and asset base position it within the sector. This context is important when...

Earlier this week, Boyd Gaming Corporation reported its first-quarter 2026 results, after investors had closely watched expectations for flat year-on-year revenue and the balance between resilient core customer play and softer destination demand. The company’s ongoing capital projects, including the Cadence Crossing opening and Sky River expansion, are now under scrutiny for how meaningfully they can offset pressure on hotel and resort-driven margins. We’ll now examine how management’s...

Fortinet (FTNT) stock is back in focus after the company received Google Cloud’s 2026 Partner of the Year Award for Workload Security, spotlighting its FortiCNAPP platform for hybrid and multi cloud protection. See our latest analysis for Fortinet. The recent Google Cloud award has arrived during a period of strong near term momentum, with Fortinet’s share price at US$87.09 after a 9.35% 7 day share price return. However, the 1 year total shareholder return is a 10.22% decline, while the 5...

Q4 earnings spark sharp move in Braze stock Braze (BRZE) recently reported Q4 earnings, with revenue up 27.9% year on year. The company beat analyst expectations on revenue, billings, and EBITDA, and the stock has climbed 25.8% since the announcement. See our latest analysis for Braze. The strong Q4 reaction comes after a mixed year, with a 27.1% 30 day share price return and a 26.1% decline year to date, while the 1 year total shareholder return is down 15.1%. Recent momentum is therefore...

Warner Music Group (NasdaqGS:WMG) has entered a landmark partnership with TuStreams in the Música Mexicana genre. The deal includes a minority investment by Warner Music Group and a global distribution agreement for TuStreams' catalog and future releases. The partnership is designed to broaden Warner Music Group's reach in Música Mexicana and connect TuStreams artists with international audiences. For investors tracking Warner Music Group at a share price of $29.31, this move comes...

Krystal Biotech (KRYS) has drawn fresh attention after recent share price moves, with the stock showing a mix of gains over the past month and year and some softness over the past 3 months. See our latest analysis for Krystal Biotech. The recent 10.34% 1 month share price return alongside an 11.76% year to date share price gain contrasts with a softer 4.56% 3 month share price return. At the same time, the 66.43% 1 year total shareholder return points to momentum that has been building over a...

What Carter's Stock Performance Suggests Right Now Carter's (CRI) has drawn fresh attention after recent trading left shares around $38.87, with the stock showing mixed returns over the past week, month, and past 3 months that may prompt closer portfolio review. See our latest analysis for Carter's. The recent 7.3% 7 day share price return and 12.8% 30 day share price return sit against a 17.1% year to date share price gain. However, the 5 year total shareholder return of a 54.5% decline...

Freshpet’s latest earnings shift focus to growth quality and cash generation Freshpet (FRPT) recently reported quarterly results that included surpassing US$1b in net sales for the first time, beating analysts’ adjusted operating income estimates, and reporting positive free cash flow. Management also highlighted expanded margins alongside these results. The share price has pulled back since the report, giving investors a fresh set of financial markers to weigh against Freshpet’s longer term...

The Trade Desk recently announced it will release its first-quarter 2026 results on May 7, alongside a webcast and call, while investor attention has intensified after CEO Jeff Green purchased US$150,000,000 of company shares and the firm highlighted continued adoption of its AI-driven advertising tools. These developments come as analysts debate the impact of growing competition, platform fee scrutiny, and evolving programmatic ad trends on The Trade Desk’s longer-term earnings potential...

Earlier this week, Exelixis drew attention after a report said a rival’s triple‑drug kidney cancer regimen failed in a Dow Jones pharma update, highlighting Exelixis as a key competitor in this treatment area. This setback for a competing approach subtly improves the perceived competitive position of Exelixis’s kidney cancer franchise at a time when oncology differentiation is critical. We’ll now explore how a rival’s failed kidney cancer regimen may influence Exelixis’s existing oncology...

Investors may be wondering if Kosmos Energy's current share price still offers value, or if most of the opportunity has already been priced in. The stock last closed at US$2.85, with returns of 10.5% over 7 days, 5.9% over 30 days, 219.2% year to date and 63.8% over 1 year. The 3 year and 5 year returns stand at a 53.6% decline and a 2.4% decline respectively. Recent coverage around Kosmos Energy has focused on its position in the energy sector and how investors are reassessing risk and...

Interparfums stock: recent performance snapshot Interparfums (IPAR) has drawn fresh attention after recent share price swings, with the stock down 3.4% over the past day and 2.1% over the past week, while month performance stands modestly positive. See our latest analysis for Interparfums. At a share price of US$91.96, Interparfums shows short term share price pressure with a 1 day share price return decline of 3.4% and a 1 year total shareholder return decline of 11.9%, pointing to fading...

Wondering if PPL at around US$37.78 is giving you value or just price noise? This article walks through what that price tag might really mean for you. The stock has seen a 4.0% decline over the last 7 days, while returns sit at 2.4% over 30 days, 7.6% year to date and 7.6% over 1 year, with longer term returns of 47.6% over 3 years and 56.8% over 5 years, which shows how the story has evolved over time. Recent coverage of PPL has focused on its role in the US utilities sector and how...

Analyst sentiment around Bunge Global (BG) has turned more favorable ahead of its upcoming earnings, as consensus forecasts for quarterly earnings per share have been revised higher, and the company also carries a positive Earnings ESP. See our latest analysis for Bunge Global. At a share price of $125.77, Bunge Global has seen momentum build, with a 7 day share price return of 4.81% and a year to date share price return of 35.76%, while the 1 year total shareholder return of 62.43% points to...

Recent performance snapshot Biohaven (BHVN) has recently caught investor attention after a one-month return of 22.2%, contrasting with a past three-month total return decline of 22.4% and a one-year total return decline of 50.1%. See our latest analysis for Biohaven. The recent 22.2% one month share price return, alongside a 4.8% one day gain at a share price of US$10.68, contrasts with a 50.1% one year total shareholder return decline. This suggests short term momentum after a tougher period...

In April 2026, Intel drew fresh investor attention as analysts highlighted accelerating demand for its server CPUs tied to AI infrastructure, alongside new partnerships such as Google’s AI and cloud collaboration and Tesla’s plan to use Intel’s upcoming 14A process at its Terafab chip project. This combination of analyst optimism, high-profile cloud and automotive customers, and a growing role for Intel’s foundry ambitions is reshaping how investors view the company’s place in the AI...

Wondering whether Advanced Micro Devices at US$303.46 still offers value after its strong run? This article breaks down what the current price might be implying about the stock. The share price performance has been strong, with returns of 17.6% over 7 days, 49.7% over 30 days, 35.8% year to date, 235.7% over 1 year, 253.1% over 3 years, and 261.2% over 5 years. Recent market attention on Advanced Micro Devices has focused on its role in high performance computing and semiconductors, with...